BRCA1 and breast cancer: BRCA1/2 mutation carriers died 20 years earlier than BC patients from the general population, indicating that age at diagnosis could be a co-variant of prognosis (HR = 1.08; 95% CI =1.07 to 1.08; p < 0.0001).